Amneal Pharmaceuticals (AMRX) Cash & Current Investments (2017 - 2026)
Amneal Pharmaceuticals' Cash & Current Investments was $127.64 million in Q2 2026, up 78.4% from $71.54 million a year earlier but down 35.4% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Amneal Pharmaceuticals came in at $282.03 million, up 155.1% from FY2024.
- Cash & Current Investments has now increased for three consecutive years, though with a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $110.55 million in FY2024 (+20.8%), $91.54 million in FY2023 (+252.4%), $25.98 million in FY2022 (-89.5%) and $247.79 million in FY2021 (-27.4%).
- Quarterly Cash & Current Investments has moved between $25.98 million (Q4 2022) and $302.66 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for seven straight quarters, with growth averaging 92.0% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q4 2023 (growth of 252.4%); the worst was Q4 2022 (a decline of 89.5%).
- Per Business Quant data, AMRX's Cash & Current Investments in the three quarters before Q2 2026 was $197.66 million (Q1 2026), $282.03 million (Q4 2025) and $201.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Amneal Pharmaceuticals | 6.53 Bn | 5.72 Bn | 334.51 Mn | 127.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 127.64 Mn |
| Mar 31, 2026 | 197.66 Mn |
| Dec 31, 2025 | 282.03 Mn |
| Sep 30, 2025 | 201.25 Mn |
| Jun 30, 2025 | 71.54 Mn |
| Mar 31, 2025 | 59.19 Mn |
| Dec 31, 2024 | 110.55 Mn |
| Sep 30, 2024 | 74.01 Mn |
| Jun 30, 2024 | 43.77 Mn |
| Mar 31, 2024 | 46.52 Mn |
| Dec 31, 2023 | 91.54 Mn |
| Sep 30, 2023 | 86.93 Mn |
| Jun 30, 2023 | 109.28 Mn |
| Mar 31, 2023 | 144.67 Mn |
| Dec 31, 2022 | 25.98 Mn |
| Sep 30, 2022 | 87.34 Mn |
| Jun 30, 2022 | 91.98 Mn |
| Mar 31, 2022 | 210.48 Mn |
| Dec 31, 2021 | 247.79 Mn |
| Sep 30, 2021 | 302.66 Mn |
API Access
Amneal Pharmaceuticals Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();